These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26883180)

  • 41. Genome-wide profiling of DNA methylation reveals preferred sequences of DNMTs in hepatocellular carcinoma cells.
    Fan H; Zhao Z; Cheng Y; Cui H; Qiao F; Wang L; Hu J; Wu H; Song W
    Tumour Biol; 2016 Jan; 37(1):877-85. PubMed ID: 26254611
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
    Zhao R; Wang N; Huang H; Ma W; Yan Q
    Liver Int; 2014 Jul; 34(6):e151-60. PubMed ID: 24529164
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CpG island methylator phenotype association with upregulated telomerase activity in hepatocellular carcinoma.
    Zhang C; Guo X; Jiang G; Zhang L; Yang Y; Shen F; Wu M; Wei L
    Int J Cancer; 2008 Sep; 123(5):998-1004. PubMed ID: 18546260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of aberrant promoter methylation of GSTP1 in the tumor and serum of Chinese human primary hepatocellular carcinoma patients.
    Wang J; Qin Y; Li B; Sun Z; Yang B
    Clin Biochem; 2006 Apr; 39(4):344-8. PubMed ID: 16527261
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker.
    Anwar SL; Albat C; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Lehmann U
    Int J Cancer; 2013 Aug; 133(3):660-70. PubMed ID: 23364900
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relationship to aflatoxin B1-DNA adducts and p53 mutation in hepatocellular carcinoma.
    Zhang YJ; Chen Y; Ahsan H; Lunn RM; Lee PH; Chen CJ; Santella RM
    Int J Cancer; 2003 Feb; 103(4):440-4. PubMed ID: 12478658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypomethylation of long interspersed nuclear element-1 (LINE-1) is associated with poor prognosis via activation of c-MET in hepatocellular carcinoma.
    Zhu C; Utsunomiya T; Ikemoto T; Yamada S; Morine Y; Imura S; Arakawa Y; Takasu C; Ishikawa D; Imoto I; Shimada M
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S729-35. PubMed ID: 24992910
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RASSF1A and DOK1 Promoter Methylation Levels in Hepatocellular Carcinoma, Cirrhotic and Non-Cirrhotic Liver, and Correlation with Liver Cancer in Brazilian Patients.
    Araújo OC; Rosa AS; Fernandes A; Niel C; Villela-Nogueira CA; Pannain V; Araujo NM
    PLoS One; 2016; 11(4):e0153796. PubMed ID: 27078152
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methylation profile of the promoter CpG islands of 14 "drug-resistance" genes in hepatocellular carcinoma.
    Ding S; Gong BD; Yu J; Gu J; Zhang HY; Shang ZB; Fei Q; Wang P; Zhu JD
    World J Gastroenterol; 2004 Dec; 10(23):3433-40. PubMed ID: 15526362
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of a non-coding KLF4 transcript generated from intron retention and downregulated in human hepatocellular carcinoma.
    Zhou J; Lai PB; Tsui SK
    Int J Oncol; 2015 Oct; 47(4):1554-62. PubMed ID: 26238073
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
    Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
    Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas.
    Gao W; Kondo Y; Shen L; Shimizu Y; Sano T; Yamao K; Natsume A; Goto Y; Ito M; Murakami H; Osada H; Zhang J; Issa JP; Sekido Y
    Carcinogenesis; 2008 Oct; 29(10):1901-10. PubMed ID: 18632756
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical significance and association of GSTP1 hypermethylation with hepatocellular carcinoma: A meta-analysis.
    Li Y; Cai Y; Chen H; Mao L
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S486-S489. PubMed ID: 29970711
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical significance of aberrant cyclin-dependent kinase-like 2 methylation in hepatocellular carcinoma.
    Zhou Y; Qiu XP; Li ZH; Zhang S; Rong Y; Yang GH; Fang-Zheng
    Gene; 2019 Jan; 683():35-40. PubMed ID: 30292871
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Integrative array-based approach identifies MZB1 as a frequently methylated putative tumor suppressor in hepatocellular carcinoma.
    Matsumura S; Imoto I; Kozaki K; Matsui T; Muramatsu T; Furuta M; Tanaka S; Sakamoto M; Arii S; Inazawa J
    Clin Cancer Res; 2012 Jul; 18(13):3541-51. PubMed ID: 22573353
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
    Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
    Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma.
    Song MA; Tiirikainen M; Kwee S; Okimoto G; Yu H; Wong LL
    PLoS One; 2013; 8(2):e55761. PubMed ID: 23437062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan.
    Hsu LS; Lee HC; Chau GY; Yin PH; Chi CW; Lui WY
    Oncol Rep; 2006 Feb; 15(2):507-11. PubMed ID: 16391877
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genome-wide DNA methylation analysis identifies candidate epigenetic markers and drivers of hepatocellular carcinoma.
    Zheng Y; Huang Q; Ding Z; Liu T; Xue C; Sang X; Gu J
    Brief Bioinform; 2018 Jan; 19(1):101-108. PubMed ID: 27760737
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of metallothionein 1G as a methylated tumor suppressor gene in human hepatocellular carcinoma using a novel method of double combination array analysis.
    Kanda M; Nomoto S; Okamura Y; Nishikawa Y; Sugimoto H; Kanazumi N; Takeda S; Nakao A
    Int J Oncol; 2009 Sep; 35(3):477-83. PubMed ID: 19639168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.